| Item Type | Name |
|
Academic Article
|
Comparison of the frequency of behavioral disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients.
|
|
Academic Article
|
Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature.
|
|
Academic Article
|
Olanzapine response in psychotic depression.
|
|
Academic Article
|
A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.
|
|
Academic Article
|
Olanzapine and haloperidol in first episode psychosis: two-year data.
|
|
Academic Article
|
A delusion assessment scale for psychotic major depression: Reliability, validity, and utility.
|
|
Academic Article
|
Weight gain during olanzapine treatment for psychotic depression: effects of dose and age.
|
|
Academic Article
|
A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).
|
|
Academic Article
|
Benzodiazepine response.
|
|
Academic Article
|
Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.
|
|
Academic Article
|
Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression.
|
|
Academic Article
|
The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.
|
|
Academic Article
|
Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD II.
|
|
Concept
|
Benzodiazepines
|
|
Academic Article
|
A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures.
|
|
Academic Article
|
Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account.
|
|
Academic Article
|
Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial.
|
|
Academic Article
|
Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study.
|
|
Academic Article
|
The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD.
|
|
Academic Article
|
Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS).
|
|
Academic Article
|
Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.
|
|
Academic Article
|
SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study.
|
|
Academic Article
|
Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression.
|
|
Academic Article
|
The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression.
|
|
Academic Article
|
Benzodiazepines Do Not Cause Suicide or Suicide Attempts.
|
|
Academic Article
|
Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II Study.
|
|
Academic Article
|
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial.
|
|
Academic Article
|
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II Study.
|
|
Academic Article
|
Genomic Investigation of Remission and Relapse of Psychotic Depression Treated with Sertraline plus Olanzapine: The STOP-PD II Study.
|
|
Academic Article
|
Effects of antipsychotic medication on functional connectivity in major depressive disorder with psychotic features.
|
|
Academic Article
|
Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic features.
|
|
Academic Article
|
Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trial.
|